期刊文献+

介孔生物活性玻璃装载和释放抗癌药物表阿霉素的研究 被引量:7

Study on the Loading and Releasing Behavior of Epirubicin Hydrochloride from Mesoporous Bioactive Glasses(MBGs)
暂未订购
导出
摘要 将介孔58S生物活性玻璃(m58S)作为抗癌药物载体评价了其对表阿霉素的装载量和释放性能.实验结果表明,m58S对亲水性药物表阿霉素的药物装载量为40%,是普通溶胶-凝胶58S生物活性玻璃的3倍多,并且具有更长效的缓释特性.研究还发现释放介质的pH值对表阿霉素的释放速率有很大影响,pH值越低,表阿霉素分子从载体材料中释放出的速率越快.因此,介孔生物活性玻璃是一种高效的药物缓释载体,且药物释放速率受释放介质pH值影响,有望成为药物控释型骨修复材料. Mesoporous bioactive glasses m58S were loaded with an anticancer drug-Epirubicin hydrochloride(EPI) and the release of the drug from the glasses was evaluated.The drug loading capacity of m58S for EPI was 40%, which was three times higher than that of conventional Sol-Gel bioactive glasses 58S.In phosphate buffered saline (PBS),the m58S-EPI system showed a sustained release behavior.Furthermore,the release rates from the EPI-m58S system increased with the decrease of pH values of the release medium.The results suggest that m58S is an effective anticancer drug carrier and its pH-related release behavior suggests that it has potential for design of controlled drug delivery bone grafting materials.
出处 《无机材料学报》 SCIE EI CAS CSCD 北大核心 2011年第1期68-72,共5页 Journal of Inorganic Materials
基金 国家重点基础研究发展973计划(2005cB522704) 国家自然科学基金(30730034) 上海市基础研究重点项目(08JC1420800) 国家高技术研究发展863计划(2007AA032317)~~
关键词 生物活性玻璃 介孔材料 药物载体 bioactive glasses mesoporous materials drug delivery system
  • 相关文献

参考文献36

  • 1Wang T W, Wu H C, Wang W R, et al. The development of magnetic degradable DP-bioglass for hyperthermia cancer therapy. J. Biomed. Mater. Res. B, 2007, 83A: 828-837.
  • 2Geraci M, Birch J M, Alston R D, et al. Cancer mortality in 13 to 29-year-olds in England and Wales, 1981-2005. Br. J. Cancer, 2007, 97: 1588-1594.
  • 3Schulman K L, Kohles J. Economic burden of metastatic bone disease in the US. Cancer, 2007, 109(11)" 2334-2342.
  • 4Anderson P, Salazar-Abshire M. Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives. Curr. Oncol. Rep., 2006, 8(6): 415-422.
  • 5Arndt C A S, Crist W M. Medical progress-common musculoskeletal rumors of childhood and adolescence. New. Eng. J. Med., 1999, 341(5): 342-352.
  • 6Marina N, Gebhardt M, Teot L, et al. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist, 2004, 9(4): 422-441.
  • 7Sandberg A A, Bridge J A. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet. Cytogen., 2003, 145(1): 1-30.
  • 8Bagi C M. Targeting of therapeutic agents to bone to treat metastatic cancer. Adv. Drug Delivery Rev., 2005, 57(7): 995-1010.
  • 9Guise T A, Mundy G R. Cancer and bone. Endocr. Rev., 1998, 19(1): 18-54.
  • 10Nagarajan R, Clohisy D R, Neglia J E et al. Function and quality-of-fife of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: the childhood cancer survivor study. Br. J. Cancer, 2004, 91(11): 1858-1865.

二级参考文献4

同被引文献33

  • 1梁军,杨志明,罗静聪,李秀群.WO-1生物衍生骨缓释材料抗感染的实验研究[J].中国修复重建外科杂志,2005,19(5):369-372. 被引量:15
  • 2黄晓晖,严晓霞,韩路,易静,雷杰,赵东元,余承忠.介孔生物活性玻璃材料在模拟体液中的用量对考察其体外生物活性的影响[J].化学学报,2006,64(9):851-857. 被引量:8
  • 3唐月军,吕春堂.医用复合生物陶瓷的研究进展[J].国际生物医学工程杂志,2006,29(2):114-116. 被引量:10
  • 4吴在德,吴肇汉.外科学.6版.北京:人民卫生出版社,2004:445-447.
  • 5崔福德;龙晓英.药剂学[M]北京:人民卫生出版社,2011.
  • 6Tanigo T,Takaoka R,Tabata Y. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augmeuts bone regenerration e[J].Journal of Controlled Releas,2010,(02):201-206.
  • 7Vuorinen S,Hein(a)m(a)ki J,Antikainen O. Sugar End-Capped Poly-d,(l)-lactides as Excipients in Oral Sustained Release Tablets[J].AAPS PHARMSCITECH,2009,(02):566-573.
  • 8AppaRao B,Shivalingam MR,Kishore Reddy YV. Design and evaluation of sustained release microcapsules containing diclofenac sodium[J].Int J Pharm Biomed Res,2010,(03):90-93.
  • 9Jordan F,Naylor A,Kelly C.A. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology In vivo studies[J].Journal of Controlled Release,2010,(02):153-160.
  • 10Vrignaud S,Anton N,Gayet P. Reverse micelle-loaded lipid nanocarriers:A novel drug delivery system for the sustained release of doxorubicin hydrochloride[J].European Journal of Pharmaceutics and Biopharmaceutics,2011,(01):197-204.

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部